China Probiotics on Leading Marketplaces: CN¥ 8.27B, +18.1%

Executive Summary#

Online probiotics dietary supplement revenue across several leading Chinese marketplaces reached CN¥ 8.27 billion in MAT2023, growing +18.1% YoY^[1], driven by expanding consumer health awareness and a broadening base of online distribution. The category has now compounded through two consecutive double-digit years, adding CN¥ 1.45 billion of revenue between MAT2021 and MAT2022 and a further CN¥ 1.27 billion into MAT2023. Within that total, the probiotics-specific category accounts for 65.8% of dietary supplement segment revenue and came to CN¥ 5.44 billion in MAT2023; every price tier in it expanded in the latest year with the premium tiers growing fastest, and jelly dosage forms surged +5,785% YoY, signaling a paradigm shift toward snack-like consumption formats.

Market Scale: Two Consecutive Double-Digit Growth Years#

Online probiotics dietary supplement revenue rose from CN¥ 5.55 billion in MAT2021 to CN¥ 7.00 billion in MAT2022 (+26.1%), and on to CN¥ 8.27 billion in MAT2023 (+18.1%)^[1]. Two consecutive years of double-digit expansion is unusual in a supplements sub-segment that only recently graduated from being an adjacency to general nutrition, and the growth is coming from a broadening base rather than from one breakout product cycle.

The structural driver is what the category itself demands of fulfilment. Probiotics are temperature-sensitive, and their perceived efficacy depends on culture viability at the point of consumption, so fulfilment quality is part of the product proposition rather than a back-office cost line. In practice the category asks the same things of any seller: short transit times and cold-chain-aware handling from warehouse to doorstep, storage guidance that survives the last mile, and merchandising able to explain strain, dose and shelf life at the point of purchase. For brands planning a China supplements launch, those are launch-plan requirements alongside audience reach, not details to be resolved after listing. Coverage here spans several leading Chinese marketplaces rather than the whole market, so the totals above should be read as a large, representative slice of online demand rather than a census.

Category revenue compounds to CN¥ 8.27 billion across three rolling years

Premiumization Accelerates Above CN¥ 500#

The above-CN¥ 500 price segment delivered the most dramatic growth, surging from CN¥ 257 million in MAT2021 to CN¥ 1.16 billion in MAT2023, representing approximately +90.8% YoY growth in the latest year^[1]. The two tiers immediately below it moved the same way: CN¥ 400-500 grew +70.5% YoY and CN¥ 300-400 grew +50.9% YoY, while CN¥ 200-300 — now the single largest tier by revenue at CN¥ 1.22 billion — added +25.0%.

This premiumization trend is primarily driven by multi-box packaging strategies, where merchants bundle multiple units into higher-value SKUs. Rather than reflecting a fundamental shift in per-unit pricing, this approach effectively increases the Average Selling Price (ASP) while offering consumers perceived bulk-purchase savings. Key dynamics include:

• Multi-box bundles elevate average transaction values above CN¥ 500
• Every price tier expanded in MAT2023, so premium demand is layering on top of the value base rather than displacing it
• CN¥ 200-300 roughly doubled and CN¥ 300-400 more than tripled their revenue contribution since MAT2021
• Subscription-based packaging emerges as a premium justification strategy

The tiers below cover the probiotics-specific category — CN¥ 5.44 billion in MAT2023, the 65.8% share cited above — rather than the full CN¥ 8.27 billion headline, so they sum to less than that total. The entry tier below CN¥ 100 also grew in MAT2023, which matters for positioning: the market is not abandoning price-sensitive consumers, it is adding premium options above an established value tier. Brands entering the category can treat the CN¥ 200-400 band as the realistic centre of gravity for a first SKU, with bundle economics — not a higher unit price — doing the work of moving into the premium tiers.

Every price tier expands in MAT2023, with the premium tiers growing fastest

Dosage Form Innovation: Jelly Surges +5,785% YoY#

Jelly format exploded at +5,785% YoY growth, reaching CN¥ 97 million in MAT2023^[1]. The surge came off a near-zero base and was driven by a single breakout probiotics enzyme jelly SKU, demonstrating how quickly snack-like product forms can capture consumer attention in the supplements category. Other emerging formats moved the same way: oral powder grew +274.7% YoY, chewable tablets +174.4%, drops +119.5% — the last driven by precision-dosing demand in infant probiotics — and gummies +88.9%.

Powder format maintained market leadership with CN¥ 1.48 billion in MAT2023 and +29.6% YoY growth. Capsules followed at CN¥ 1.04 billion (+23.3% YoY), granule drinks at CN¥ 568 million (+27.6% YoY) and tablets at CN¥ 262 million (+43.3% YoY). Together, powder and capsule account for more than three-fifths of the revenue across the dosage forms shown here — CN¥ 2.52 billion of CN¥ 4.04 billion — so the established formats are not being displaced; they are growing solidly while a long tail of newer forms scales from a much smaller base. Note that the forms charted below do not exhaust the category: they sum to CN¥ 4.04 billion against the probiotics-specific category's CN¥ 5.44 billion, with the remainder spread across forms outside this set. The trajectory is nonetheless clear — incremental growth increasingly favours formats that combine functional efficacy with consumption convenience.

Two traditional formats anchor category revenue, with a long tail of emerging forms

Key Takeaways#

• Online probiotics revenue across leading Chinese marketplaces reached CN¥ 8.27 billion in MAT2023, growing +18.1% YoY, after +26.1% the year before
• Within that total, the probiotics-specific category accounts for 65.8% of dietary supplement segment revenue — CN¥ 5.44 billion in MAT2023 — and is the base for the price tiers below
• The above-CN¥ 500 price segment surged ~+90.8% YoY to CN¥ 1.16 billion, driven by multi-box bundling rather than higher per-unit pricing
• Every price tier expanded in MAT2023, so premiumization is additive to the value tier rather than a replacement for it
• Jelly format delivered +5,785% YoY growth from a near-zero base, validating consumer appetite for snack-like supplement forms

## About the Data

This analysis draws on Moojing Market Intelligence data covering MAT2023 (rolling annual period ending January 2023). Moojing analyses brand and category performance across major Chinese e-commerce platforms. Coverage for this analysis spans several leading Chinese online marketplaces and the online channel only; it is not a whole-market census. For full methodology and additional insights, see the complete Probiotics Dietary Supplements whitepaper.